Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04219774Phase 2Completed
Phase 2, randomised, open-label trial (3 arms), sponsored by Duke University. Primary endpoints: Montreal Cognitive Assessment at 12 months and Composite Cognitive Score at 12 months. Started May 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04219774.